Intra-Cellular Therapies (ITCI) Reports Q1 Loss of $0.63/Share

May 8, 2019 7:40 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q1 EPS of ($0.63), versus ($0.65) reported last year.

For earnings history and earnings-related data on Intra-Cellular Therapies (ITCI) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

The Children's Investment Fund (TCI), Earnings